Qualified research institutions that develop their own pharmaceuticals will be eligible to hold marketing authorization permits in China under new legal guidance that went into effect in late September. Since 2015, when China first began implementing its Marketing Authorization Holder (MAH) system,... Read More
Moving to speed the approval of needed pharmaceuticals, the Philippines health authorities are making it possible to register some vaccines, biologicals, and other drugs for sale in the archipelago nation if they have already met approval requirements abroad. The order issued in... Read More
Radio Frequency Identification (RFID), a fast-developing technology that uses radio waves to collect and transfer data, is increasingly being adopted in healthcare markets across the Asia Pacific region and around the globe. A study by Precedence Research found sales of the technology,... Read More
With the COVID-19 pandemic bringing into focus the need for better collection and use of data in healthcare, health authorities in Vietnam are pushing to accelerate the development of artificial intelligence platform and technologies. In June, the Ministry of Health announced an... Read More
In response to growing concern that pharmaceuticals imported to China do not always adhere to the same safety guidelines they follow when marketed abroad, Chinese health authorities in October put forward a proposal to update domestic regulations governing drug recalls. The proposed... Read More
The long-simmering question of when and how Japan will implement a proposed plan to evaluate and revise drug prices annually, instead of every two years, may finally be resolved next year. That is when a survey being conducted by the Ministry of... Read More
Moving to better its system for settling patent disputes while also providing generic drugs a market pathway, Chinese authorities in September issued a draft policy addressing the relationship between market approval of generic drugs and the patent status of branded equivalents. The... Read More
Accelerating efforts to make the island of Hainan into a center for medical innovation—and medical tourism — local authorities have approved an insurance plan for the island that will cover foreign drugs and treatments not yet approved on the mainland. The government-backed... Read More
Thirty-three pharmaceuticals will be added to the 18th edition of the Japanese Pharmacopoeia, if the draft edition of the official compendium of government approved medicines is finalized, as expected. The 33 new products include antibiotics, excipients and biologics, as well as a... Read More
Western investors are increasingly investing in Chinese biotechnology firms, driven by a surge in demand for cutting edge treatments for the novel coronavirus and other new therapies being developed in China. Over the past five years, Chinese firms have moved away from... Read More